Test for Immortality in the Reference Lab
Early-stage biotechnology is hardly the most popular investment in health care these days, but Geron is doing just fine despite the fact that its clinical target, telomerase, still awaits definitive proof of value and that it has yet to clone the entire molecule.
You may also be interested in...
Due to the COVID-19 crisis, the US Medicare agency is extending the length of time it will support its Comprehensive Care for Joint Replacement bundled payment reimbursement model.
With inspectors no longer out in the field, they have more time to wrap up work on previously completed facility evaluations, attorney Howard Sklamberg says; inspections freeze could delay manufacturers’ abilities to bring facilities into compliance following adverse inspection findings, as well as agency reclassifications of facility status.
Philips will make 43,000 medical ventilators by the end of 2020 for use in the US and manufacture 2,500 more for the Strategic National Stockpile in a contract worth more than half a billion dollars.